Psyence Biomedical Ltd Stock Technical Analysis

PBM Stock  USD 3.51  0.17  5.09%   
As of the 29th of November, Psyence Biomedical holds the Variance of 85.67, risk adjusted performance of (0.23), and Coefficient Of Variation of (320.97). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Psyence Biomedical, as well as the relationship between them. Please check Psyence Biomedical risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Psyence Biomedical is priced some-what accurately, providing market reflects its current price of 3.51 per share. Given that Psyence Biomedical has information ratio of (0.33), we recommend you to check out Psyence Biomedical's recent market performance to make sure the company can sustain itself at a future point.

Psyence Biomedical Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Psyence, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Psyence
  
Psyence Biomedical's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Psyence Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Psyence Biomedical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Psyence Biomedical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Psyence Biomedical Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Psyence Biomedical volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Psyence Biomedical Trend Analysis

Use this graph to draw trend lines for Psyence Biomedical Ltd. You can use it to identify possible trend reversals for Psyence Biomedical as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Psyence Biomedical price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Psyence Biomedical Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Psyence Biomedical Ltd applied against its price change over selected period. The best fit line has a slop of   0.15  , which may imply that the returns on investment in Psyence Biomedical Ltd will continue to fail. It has 122 observation points and a regression sum of squares at 903.73, which is the sum of squared deviations for the predicted Psyence Biomedical price change compared to its average price change.

About Psyence Biomedical Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Psyence Biomedical Ltd on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Psyence Biomedical Ltd based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Psyence Biomedical price pattern first instead of the macroeconomic environment surrounding Psyence Biomedical. By analyzing Psyence Biomedical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Psyence Biomedical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Psyence Biomedical specific price patterns or momentum indicators. Please read more on our technical analysis page.

Psyence Biomedical November 29, 2024 Technical Indicators

Most technical analysis of Psyence help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Psyence from various momentum indicators to cycle indicators. When you analyze Psyence charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Psyence Biomedical is a strong investment it is important to analyze Psyence Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psyence Biomedical's future performance. For an informed investment choice regarding Psyence Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.82)
Return On Assets
(1.26)
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.